211 related articles for article (PubMed ID: 37796986)
1. Deficiency of orexin signaling during sleep is involved in abnormal REM sleep architecture in narcolepsy.
Ito H; Fukatsu N; Rahaman SM; Mukai Y; Izawa S; Ono D; Kilduff TS; Yamanaka A
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2301951120. PubMed ID: 37796986
[TBL] [Abstract][Full Text] [Related]
2. Melanin-concentrating hormone neurons contribute to dysregulation of rapid eye movement sleep in narcolepsy.
Naganuma F; Bandaru SS; Absi G; Mahoney CE; Scammell TE; Vetrivelan R
Neurobiol Dis; 2018 Dec; 120():12-20. PubMed ID: 30149182
[TBL] [Abstract][Full Text] [Related]
3. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.
Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M
Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic MCH Neuron Activity Dynamics during Cataplexy of Narcolepsy.
Sun Y; Liu M
eNeuro; 2020; 7(2):. PubMed ID: 32303567
[TBL] [Abstract][Full Text] [Related]
5. Dual orexin and MCH neuron-ablated mice display severe sleep attacks and cataplexy.
Hung CJ; Ono D; Kilduff TS; Yamanaka A
Elife; 2020 Apr; 9():. PubMed ID: 32314734
[TBL] [Abstract][Full Text] [Related]
6. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.
Dauvilliers Y; Jennum P; Plazzi G
Sleep Med; 2013 Aug; 14(8):775-81. PubMed ID: 23219054
[TBL] [Abstract][Full Text] [Related]
7. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
[TBL] [Abstract][Full Text] [Related]
8. Sleep transitions in hypocretin-deficient narcolepsy.
Sorensen GL; Knudsen S; Jennum P
Sleep; 2013 Aug; 36(8):1173-7. PubMed ID: 23904677
[TBL] [Abstract][Full Text] [Related]
9. Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy.
Williams RH; Tsunematsu T; Thomas AM; Bogyo K; Yamanaka A; Kilduff TS
J Neurosci; 2019 Nov; 39(47):9435-9452. PubMed ID: 31628177
[TBL] [Abstract][Full Text] [Related]
10. Behavioral state instability in orexin knock-out mice.
Mochizuki T; Crocker A; McCormack S; Yanagisawa M; Sakurai T; Scammell TE
J Neurosci; 2004 Jul; 24(28):6291-300. PubMed ID: 15254084
[TBL] [Abstract][Full Text] [Related]
11. Neurobiology of cataplexy.
Seifinejad A; Vassalli A; Tafti M
Sleep Med Rev; 2021 Dec; 60():101546. PubMed ID: 34607185
[TBL] [Abstract][Full Text] [Related]
12. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat.
Beuckmann CT; Sinton CM; Williams SC; Richardson JA; Hammer RE; Sakurai T; Yanagisawa M
J Neurosci; 2004 May; 24(18):4469-77. PubMed ID: 15128861
[TBL] [Abstract][Full Text] [Related]
13. The inappropriate occurrence of rapid eye movement sleep in narcolepsy is not due to a defect in homeostatic regulation of rapid eye movement sleep.
Roman A; Meftah S; Arthaud S; Luppi PH; Peyron C
Sleep; 2018 Jun; 41(6):. PubMed ID: 29522212
[TBL] [Abstract][Full Text] [Related]
14. Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models.
Irukayama-Tomobe Y; Ogawa Y; Tominaga H; Ishikawa Y; Hosokawa N; Ambai S; Kawabe Y; Uchida S; Nakajima R; Saitoh T; Kanda T; Vogt K; Sakurai T; Nagase H; Yanagisawa M
Proc Natl Acad Sci U S A; 2017 May; 114(22):5731-5736. PubMed ID: 28507129
[TBL] [Abstract][Full Text] [Related]
15. A Discrete Glycinergic Neuronal Population in the Ventromedial Medulla That Induces Muscle Atonia during REM Sleep and Cataplexy in Mice.
Uchida S; Soya S; Saito YC; Hirano A; Koga K; Tsuda M; Abe M; Sakimura K; Sakurai T
J Neurosci; 2021 Feb; 41(7):1582-1596. PubMed ID: 33372061
[TBL] [Abstract][Full Text] [Related]
16. Induction of narcolepsy-like symptoms by orexin receptor antagonists in mice.
Kaushik MK; Aritake K; Cherasse Y; Imanishi A; Kanbayashi T; Urade Y; Yanagisawa M
Sleep; 2021 Aug; 44(8):. PubMed ID: 33609365
[TBL] [Abstract][Full Text] [Related]
17. Orexin neurons are necessary for the circadian control of REM sleep.
Kantor S; Mochizuki T; Janisiewicz AM; Clark E; Nishino S; Scammell TE
Sleep; 2009 Sep; 32(9):1127-34. PubMed ID: 19750917
[TBL] [Abstract][Full Text] [Related]
18. Sex-related differences within sleep-wake dynamics, cataplexy, and EEG fast-delta power in a narcolepsy mouse model.
Piilgaard L; Rose L; Gylling Hviid C; Kohlmeier KA; Kornum BR
Sleep; 2022 Jul; 45(7):. PubMed ID: 35266540
[TBL] [Abstract][Full Text] [Related]
19. The development of sleep/wake disruption and cataplexy as hypocretin/orexin neurons degenerate in male vs. female Orexin/tTA; TetO-DTA Mice.
Sun Y; Tisdale R; Park S; Ma SC; Heu J; Haire M; Allocca G; Yamanaka A; Morairty SR; Kilduff TS
Sleep; 2022 Dec; 45(12):. PubMed ID: 35182424
[TBL] [Abstract][Full Text] [Related]
20. Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice.
Fujiki N; Cheng T; Yoshino F; Nishino S
Exp Neurol; 2009 May; 217(1):46-54. PubMed ID: 19416673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
